Lipopolysaccharides (LPS) antibody

Catalog No. ABIN7232847

The Mouse Monoclonal anti-Lipopolysaccharides (LPS) antibody (Clone 4CE4) (ABIN7232847) specifically detects Lipopolysaccharides (LPS) in ELISA. The antibody is reactive with Legionella pneumophila samples.

Quick Overview for Lipopolysaccharides (LPS) antibody (ABIN7232847)

Target: Lipopolysaccharides (LPS)

Reactivity: Legionella pneumophila

Host: Mouse

Clonality: Monoclonal

Conjugate: This Lipopolysaccharides (LPS) antibody is un-conjugated

Application: ELISA

Clone: 4CE4

Product Details anti-Lipopolysaccharides (LPS) Antibody

Purpose: Anti-Legionella pneumophila Mouse Monoclonal Antibody

Specificity: This antibody recognizes LPS of L. pneumophila serogroup 1 (SG1). It does not react with serogroups 2-9, Legionella bozemanae, or Branhamella catarrharlis.

Cross-Reactivity: Legionella pneumophila

Immunogen: L. pneumophila serogroup 1 LPS conjugated to BSA.

Isotype: IgG1

Application Details

Application Notes: ELISA: use at 0.1-1.0 μg/mL with LPS on the solid phase at 5 μg/mL.
These are recommended concentrations.
End users should determine optimal concentrations for their applications.

Restrictions: For Research Use only

Handling

Format: Liquid

Reconstitution: Dilute in PBS or medium that is identical to that used in the assay system.

Concentration: 1.0 mg/mL

Buffer: PBS, 0.02 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: This antibody is stable for at least one (1) year if stored at -20°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles.

Target Details for Lipopolysaccharides (LPS)

Target: Lipopolysaccharides (LPS)

Alternative Name: LPS

Target Type: Chemical

Background: Legionella pneumophila are Gram- negative aerobic coccobacilli isolated from natural and artificial fresh water reservoirs. The outer membrane of L. pneumophila is comprised of a unique lipopolysaccharide (LPS) which is less endotoxic than enterobacterial LPS. Serogroups of L. pneumophila are classified based on O- antigen determinants of their cell wall side chains. L. pneumophila is pathogenic for humans, and it has no known soil or animal sources. It is responsible for more than 98 % of the cases of Legionnaires' Disease, and about 95 % of cases are due to serogroup 1. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, blood, and urine.